Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Depreciation & Amortization (CF) (2023)

Updated

Raphael Pharmaceutical (RAPH) posted Depreciation & Amortization (CF) of $1,000 for Q1 2023.

Analysis

Raphael Pharmaceutical (RAPH) Depreciation & Amortization (CF) (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.96 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 194.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.93 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 98.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.62 Bn
10 Raphael Pharmaceutical 30.47 Mn 30.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1,000.00
API Access

Raphael Pharmaceutical Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RAPH&period=max&api_key=YOUR_API_KEY